APOLIPOPROTEIN-E INCREASES THE FIBRILLOGENIC POTENTIAL OF SYNTHETIC PEPTIDES DERIVED FROM ALZHEIMERS, GELSOLIN AND AA AMYLOIDS

被引:47
作者
SOTO, C
CASTANO, EM
PRELLI, F
KUMAR, RA
BAUMANN, M
机构
[1] NYU,MED CTR,DEPT PATHOL,NEW YORK,NY 10016
[2] HELSINKI UNIV,INST BIOMED,DEPT MED CHEM,SF-00014 HELSINKI,FINLAND
关键词
APOLIPOPROTEIN E; AMYLOIDOGENIC CONFORMATION; AMYLOIDOSIS; ALZHEIMERS DISEASE; PATHOLOGICAL CHAPERONE;
D O I
10.1016/0014-5793(95)00863-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein E (apoE) has been found in association with several differents types of systemic and cerebral amyloid deposits and the presence of the epsilon 4 allele constitutes a risk factor for Alzheimer's disease. It has been shown that apoE binds and promotes the fibrillogenesis in vitro of Alzheimer's amyloid beta-peptide, suggesting an important role for apoE in the modulation of amyloidogenesis, Due to the co-localization of apoE with several biochemically distinct amyloid deposits, it has been proposed that apoE plays a general role modulating and/or participating in amyloidosis, In the present study, we show for the first time that apoE, isolated from human plasma, increases fibril formation of synthetic peptides comprising the amyloidogenic sequences of gelsolin amyloid related to familial amyloidosis Finnish type, and amyloid A found in secondary amyloidosis and familial Mediterranean fever. Our results suggest that apoE acts as a general pathological chaperone in various amyloidoses by enhancing the transition from soluble peptides into amyloid-forming, pathological molecules.
引用
收藏
页码:110 / 114
页数:5
相关论文
共 29 条
  • [1] MAJOR PROTEINS OF HUMAN AND MONKEY AMYLOID SUBSTANCE - COMMON PROPERTIES INCLUDING UNUSUAL N-TERMINAL AMINO ACID SEQUENCES
    BENDITT, EP
    ERIKSEN, N
    HERMODSON, MA
    ERICSSON, LH
    [J]. FEBS LETTERS, 1971, 19 (02) : 169 - +
  • [2] Alzheimer's Disease from the Perspective of the Systemic and Localized Forms of Amyloidosis
    Castano, Eduardo M.
    Frangione, Blas
    [J]. BRAIN PATHOLOGY, 1991, 1 (04) : 263 - 271
  • [3] FIBRILLOGENESIS IN ALZHEIMERS-DISEASE OF AMYLOID-BETA PEPTIDES AND APOLIPOPROTEIN-E
    CASTANO, EM
    PRELLI, F
    WISNIEWSKI, T
    GOLABEK, A
    KUMAR, RA
    SOTO, C
    FRANGIONE, B
    [J]. BIOCHEMICAL JOURNAL, 1995, 306 : 599 - 604
  • [4] CASTANO EM, 1995, IN PRESS J BIOL CHEM
  • [5] SP-40,40 IS A CONSTITUENT OF ALZHEIMERS AMYLOID
    CHOIMIURA, NH
    IHARA, Y
    FUKUCHI, K
    TAKEDA, M
    NAKANO, Y
    TOBE, T
    TOMITA, M
    [J]. ACTA NEUROPATHOLOGICA, 1992, 83 (03) : 260 - 264
  • [6] GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES
    CORDER, EH
    SAUNDERS, AM
    STRITTMATTER, WJ
    SCHMECHEL, DE
    GASKELL, PC
    SMALL, GW
    ROSES, AD
    HAINES, JL
    PERICAKVANCE, MA
    [J]. SCIENCE, 1993, 261 (5123) : 921 - 923
  • [7] CORIA F, 1988, LAB INVEST, V58, P454
  • [8] GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027
  • [9] ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN
    GLENNER, GG
    WONG, CW
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) : 885 - 890
  • [10] AMINO-ACID SEQUENCE OF A MAJOR NONIMMUNOGLOBULIN COMPONENT OF SOME AMYLOID FIBRILS
    LEVIN, M
    PRAS, M
    FRANGIONE, B
    FRANKLIN, EC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1972, 51 (10) : 2773 - +